6.
Lye J, Delaney D, Leith F, Sardesai V, McLenachan S, Chen F
. Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing Loss. Biomedicines. 2023; 11(12).
PMC: 10741758.
DOI: 10.3390/biomedicines11123347.
View
7.
Arlt M, Wilson T, Glover T
. Replication stress and mechanisms of CNV formation. Curr Opin Genet Dev. 2012; 22(3):204-10.
PMC: 3371136.
DOI: 10.1016/j.gde.2012.01.009.
View
8.
Abe S, Nishio S, Yokota Y, Moteki H, Kumakawa K, Usami S
. Diagnostic pitfalls for -related hearing loss: A novel deletion detected by Array-CGH analysis in a Japanese patient with congenital profound hearing loss. Clin Case Rep. 2018; 6(11):2111-2116.
PMC: 6230644.
DOI: 10.1002/ccr3.1800.
View
9.
Rodriguez-Paris J, Tamayo M, Gelvez N, Schrijver I
. Allele-specific impairment of GJB2 expression by GJB6 deletion del(GJB6-D13S1854). PLoS One. 2011; 6(6):e21665.
PMC: 3126855.
DOI: 10.1371/journal.pone.0021665.
View
10.
Puig M, Casillas S, Villatoro S, Caceres M
. Human inversions and their functional consequences. Brief Funct Genomics. 2015; 14(5):369-79.
PMC: 4576756.
DOI: 10.1093/bfgp/elv020.
View
11.
Canoy R, Shmakova A, Karpukhina A, Shepelev M, Germini D, Vassetzky Y
. Factors That Affect the Formation of Chromosomal Translocations in Cells. Cancers (Basel). 2022; 14(20).
PMC: 9600575.
DOI: 10.3390/cancers14205110.
View
12.
Wilch E, Azaiez H, Fisher R, Elfenbein J, Murgia A, Birkenhager R
. A novel DFNB1 deletion allele supports the existence of a distant cis-regulatory region that controls GJB2 and GJB6 expression. Clin Genet. 2010; 78(3):267-74.
PMC: 2919588.
DOI: 10.1111/j.1399-0004.2010.01387.x.
View
13.
Hoefsloot L, Roux A, Bitner-Glindzicz M
. EMQN Best Practice guidelines for diagnostic testing of mutations causing non-syndromic hearing impairment at the DFNB1 locus. Eur J Hum Genet. 2013; 21(11):1325-9.
PMC: 3798855.
DOI: 10.1038/ejhg.2013.83.
View
14.
Sugiyama K, Moteki H, Kitajiri S, Kitano T, Nishio S, Yamaguchi T
. Mid-Frequency Hearing Loss Is Characteristic Clinical Feature of -Associated Hearing Loss. Genes (Basel). 2019; 10(9).
PMC: 6770988.
DOI: 10.3390/genes10090715.
View
15.
Laurent S, Gehrig C, Nouspikel T, Amr S, Oza A, Murphy E
. Molecular characterization of pathogenic OTOA gene conversions in hearing loss patients. Hum Mutat. 2021; 42(4):373-377.
PMC: 8750238.
DOI: 10.1002/humu.24167.
View
16.
Nishio S, Usami S
. Frequency of the STRC-CATSPER2 deletion in STRC-associated hearing loss patients. Sci Rep. 2022; 12(1):634.
PMC: 8755823.
DOI: 10.1038/s41598-021-04688-5.
View
17.
Sirmaci A, Duman D, Ozturkmen-Akay H, Erbek S, Incesulu A, Ozturk-Hismi B
. Mutations in TMC1 contribute significantly to nonsyndromic autosomal recessive sensorineural hearing loss: a report of five novel mutations. Int J Pediatr Otorhinolaryngol. 2009; 73(5):699-705.
DOI: 10.1016/j.ijporl.2009.01.005.
View
18.
Astuto L, Bork J, Weston M, Askew J, Fields R, Orten D
. CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet. 2002; 71(2):262-75.
PMC: 379159.
DOI: 10.1086/341558.
View
19.
Adato A, Weil D, Kalinski H, Pel-Or Y, Ayadi H, Petit C
. Mutation profile of all 49 exons of the human myosin VIIA gene, and haplotype analysis, in Usher 1B families from diverse origins. Am J Hum Genet. 1997; 61(4):813-21.
PMC: 1716000.
DOI: 10.1086/514899.
View
20.
Sodi A, Mariottini A, Passerini I, Murro V, Tachyla I, Bianchi B
. MYO7A and USH2A gene sequence variants in Italian patients with Usher syndrome. Mol Vis. 2015; 20:1717-31.
PMC: 4279600.
View